Table 3.
The 3D Gamma passing rates between the dose distributions calculated on and the corresponding of the 10 testing patients with a threshold of 3%/3mm/10% and 2%/2mm/10% for both the wMAE model and the M+S model, respectively.
PATIENT | 3%/3mm/10% (wMAE) / (M+S) | 2%/2mm/10% (wMAE) / (M+S) |
---|---|---|
| ||
#1 | 0.999 / 0.998 | 0.997 / 0.996 |
#2 * | 0.996 / 0.965 | 0.98 / 0.926 |
#3 | 1.0 / 0.991 | 0.999 / 0.977 |
#4 | 1.0 / 0.999 | 0.999 / 0.999 |
#5 | 0.995 / 0.943 | 0.978 / 0.913 |
#6 * | 0.966 / 0.976 | 0.921 / 0.934 |
#7 | 1.0 / 0.979 | 1.0 / 0.970 |
#8 | 1.0 / 0.979 | 1.0 / 0.970 |
#9 | 0.999 / 0.924 | 0.991 / 0.811 |
#10 * | 0.921 / 0.924 | 0.899 / 0.902 |
Average | 0.986±0.026 / 0.963±0.029 | 0.977±0.036 / 0.945±0.062 |
Average(photon) | 0.995±0.012 / 0.974±0.029 | 0.987±0.029 / 0.955±0.067 |
Average(proton) | 0.971±0.043 / 0.944±0.020 | 0.953±0.047 / 0.907±0.007 |
indicates that the patient was treated with proton therapy.